Medipixel

Medipixel is a global healthcare company based in Seoul, South Korea, that focuses on using artificial intelligence (AI) technology to enhance human health, particularly in cardiovascular interventions. Founded in 2017, the company develops Software as a Medical Device (SaMD) that integrates into clinical workflows, providing faster and more accurate real-time analysis solutions for cardiovascular procedures. The core product, MPXA, is an AI-powered automated cardiovascular vessel analysis software designed to assist medical professionals during catheterization lab procedures. It utilizes advanced deep learning techniques to analyze cardiovascular images with high accuracy and delivers quantitative assessments in an average of 1.8 seconds. This enables rapid clinical decision-making while maintaining procedural workflow. Medipixel targets healthcare providers involved in cardiovascular interventions, including hospitals and catheterization labs worldwide. The company aims to improve patient outcomes and quality of life through its innovative AI healthcare solutions. Medipixel has experienced significant financial growth, with revenues increasing from under $1 million in 2020 to approximately $3.2 million in 2023, supported by multiple funding rounds totaling around $24.3 million.

• Employees40
• Founded2017
• Total Funding$200000